ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/07/27 | 2,112 | 2,119 | 2,100 | 2,119 | +16 | +0.8% | 40,400 |
2021/07/26 | 2,116 | 2,116 | 2,090 | 2,103 | +8 | +0.4% | 45,500 |
2021/07/21 | 2,100 | 2,103 | 2,081 | 2,095 | +15 | +0.7% | 68,200 |
2021/07/20 | 2,063 | 2,087 | 2,059 | 2,080 | +17 | +0.8% | 47,600 |
2021/07/19 | 2,082 | 2,084 | 2,050 | 2,063 | -19 | -0.9% | 75,600 |
2021/07/16 | 2,085 | 2,100 | 2,080 | 2,082 | -7 | -0.3% | 49,900 |
2021/07/15 | 2,107 | 2,109 | 2,083 | 2,089 | -14 | -0.7% | 76,800 |
2021/07/14 | 2,098 | 2,118 | 2,095 | 2,103 | -3 | -0.1% | 92,700 |
2021/07/13 | 2,097 | 2,106 | 2,089 | 2,106 | +23 | +1.1% | 45,900 |
2021/07/12 | 2,072 | 2,100 | 2,066 | 2,083 | +31 | +1.5% | 92,100 |
2021/07/09 | 2,025 | 2,060 | 2,019 | 2,052 | +3 | +0.1% | 111,300 |
2021/07/08 | 2,036 | 2,065 | 2,036 | 2,049 | +13 | +0.6% | 85,800 |
2021/07/07 | 2,058 | 2,058 | 2,026 | 2,036 | -38 | -1.8% | 91,500 |
2021/07/06 | 2,081 | 2,083 | 2,061 | 2,074 | -7 | -0.3% | 85,500 |
2021/07/05 | 2,088 | 2,094 | 2,071 | 2,081 | -17 | -0.8% | 102,500 |
2021/07/02 | 2,104 | 2,104 | 2,090 | 2,098 | -6 | -0.3% | 105,800 |
2021/07/01 | 2,105 | 2,107 | 2,095 | 2,104 | +9 | +0.4% | 60,800 |
2021/06/30 | 2,114 | 2,115 | 2,095 | 2,095 | -13 | -0.6% | 69,800 |
2021/06/29 | 2,100 | 2,112 | 2,090 | 2,108 | -13 | -0.6% | 53,600 |
2021/06/28 | 2,115 | 2,121 | 2,099 | 2,121 | +14 | +0.7% | 62,600 |
2021/06/25 | 2,118 | 2,118 | 2,098 | 2,107 | +8 | +0.4% | 51,800 |
2021/06/24 | 2,104 | 2,113 | 2,092 | 2,099 | -5 | -0.2% | 50,100 |
2021/06/23 | 2,112 | 2,120 | 2,098 | 2,104 | -5 | -0.2% | 42,900 |
2021/06/22 | 2,068 | 2,109 | 2,062 | 2,109 | +61 | +3% | 55,100 |
2021/06/21 | 2,069 | 2,069 | 2,047 | 2,048 | -35 | -1.7% | 60,100 |
2021/06/18 | 2,102 | 2,106 | 2,083 | 2,083 | -14 | -0.7% | 94,300 |
2021/06/17 | 2,100 | 2,103 | 2,089 | 2,097 | -7 | -0.3% | 35,700 |
2021/06/16 | 2,100 | 2,106 | 2,086 | 2,104 | -2 | -0.1% | 60,300 |
2021/06/15 | 2,098 | 2,113 | 2,082 | 2,106 | +8 | +0.4% | 71,200 |
2021/06/14 | 2,119 | 2,119 | 2,094 | 2,098 | -10 | -0.5% | 52,100 |
2021/06/11 | 2,121 | 2,121 | 2,094 | 2,108 | +5 | +0.2% | 92,700 |
2021/06/10 | 2,104 | 2,110 | 2,094 | 2,103 | -12 | -0.6% | 91,500 |
2021/06/09 | 2,114 | 2,126 | 2,100 | 2,115 | +6 | +0.3% | 70,500 |
2021/06/08 | 2,096 | 2,124 | 2,095 | 2,109 | +7 | +0.3% | 87,600 |
2021/06/07 | 2,093 | 2,110 | 2,090 | 2,102 | +9 | +0.4% | 63,200 |
2021/06/04 | 2,104 | 2,104 | 2,083 | 2,093 | -11 | -0.5% | 54,500 |
2021/06/03 | 2,077 | 2,125 | 2,076 | 2,104 | +12 | +0.6% | 69,600 |
2021/06/02 | 2,100 | 2,104 | 2,066 | 2,092 | -14 | -0.7% | 156,100 |
2021/06/01 | 2,106 | 2,112 | 2,099 | 2,106 | +14 | +0.7% | 74,900 |
2021/05/31 | 2,109 | 2,125 | 2,088 | 2,092 | -20 | -0.9% | 111,100 |
2021/05/28 | 2,069 | 2,113 | 2,069 | 2,112 | +44 | +2.1% | 67,000 |
2021/05/27 | 2,062 | 2,105 | 2,062 | 2,068 | -12 | -0.6% | 165,200 |
2021/05/26 | 2,041 | 2,083 | 2,037 | 2,080 | +30 | +1.5% | 79,800 |
2021/05/25 | 2,045 | 2,054 | 2,040 | 2,050 | +5 | +0.2% | 73,500 |
2021/05/24 | 2,032 | 2,048 | 2,024 | 2,045 | +13 | +0.6% | 35,700 |
2021/05/21 | 2,022 | 2,041 | 2,022 | 2,032 | +10 | +0.5% | 46,900 |
2021/05/20 | 2,016 | 2,032 | 2,015 | 2,022 | +6 | +0.3% | 39,100 |
2021/05/19 | 1,995 | 2,016 | 1,990 | 2,016 | -5 | -0.2% | 55,600 |
2021/05/18 | 2,009 | 2,028 | 2,007 | 2,021 | +12 | +0.6% | 49,400 |
2021/05/17 | 2,006 | 2,022 | 2,006 | 2,009 | -1 | ±0% | 58,100 |
1001~
1050
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 204,700円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 311,500円 | +5.1% | -7.0% | 2.57% | 20.45倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 241,900円 | +4.1% | -3.1% | 2.40% | 21.01倍 | 1.83倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,500円 | -2.4% | -52.3% | 3.74% | 18.25倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム